Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans

NCT01851967 | Completed

• 1 other identifier: 2012-P-002340
• Study Type: interventional
• Target: 112
• Locations: 2 countries
• Sites: 2

Brief Summary

This study aims to evaluate efficacy and acceptability of the Chinese language version of MoodGYM as a therapeutic intervention in treating symptoms of depression in community dwelling Chinese Americans in the Boston area. Hypothesis 1: Participants enrolled in MoodGYM will show a significant decrease in depressive symptoms after completion of the 5 modules. Hypothesis 2: Participants enrolled in MoodGYM will show significantly improved dysfunctional thinking. Hypothesis 3: Participants enrolled in MoodGym will rate this program as culturally acceptable.

Conditions

Major Depressive Disorder

Keywords

Major depressive disorder; Cognitive behavioral therapy; Computerized CBT; Online CBT

Outcome Measures

Primary Outcomes (1)

• Change in Center for Epidemiologic Studies Depression Scale (CES-D)

  The CES-D scale is a short self-report scale designed to measure depressive symptomatology in the general population. Each of the 20 items in this instrument is assigned one value of 0, 1, 2 or 3. High scores on the CES-D indicate high levels of distress.

  Weeks 0, 6 (pre/post)

Study Arms (1)

MoodGYM

EXPERIMENTAL

This study is a single-arm intervnetion. All subjects will be assigned to receive six weeks of online CBT through MoodGYM.

Other: MoodGYM

Interventions

MoodGYM OTHER

MoodGYM, a publicly-available online CBT program developed by the Centre for Mental Health Research at The Australian National University has been shown by multiple studies to be effective in reducing symptoms of depression. MoodGYM consists of five interactive modules. Participants will be asked to complete one module each week and progress through the program sequentially.

MoodGYM

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Resident of the US, but self-identified as Chinese origin
• At least 18 years of age
• Proficiency in Chinese, including the ability to read Chinese
• Access to computer and internet
• Scores \> 10 on the Chinese bilingual patient health questionnaire -9 item (PHQ-9)

You may not qualify if:

• Current ongoing psychiatric or psychological treatment
• Using illicit drugs or consumption \> 3 standard drinks in a day
• Currently experiencing a psychotic illness
• Past or current history of schizophrenia or bipolar disorder
• ECT during the last year
• Current active suicidal or self-injurious potential necessitating immediate face-to-face treatment

Sponsors & Collaborators

• Massachusetts General Hospital: lead

Study Sites (2)

Massachusetts General Hospital Depression Clinical and Research Program

Boston, Massachusetts, 02114, United States

Location

Ying Wang

Beijing, China

Location

MeSH Terms

Conditions

Depressive Disorder, Major

Condition Hierarchy (Ancestors)

Depressive Disorder; Mood Disorders; Mental Disorders

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principle Investigator / Psychiatrist

Study Record Dates

• First Submitted: January 8, 2013
• First Posted: May 13, 2013
• Study Start: September 1, 2014
• Primary Completion: December 1, 2015
• Study Completion: November 1, 2016
• Last Updated: December 1, 2016

Record last verified: 2016-11

Locations

US (1); CN (1)